patientMpower is a digital healthcare company with Main offices in USA, Ireland and UK. The company provide technology solutions for people living with long term illnesses. patientMpower is passionate about empowering better outcomes by enabling patients to better manage their care and providing unique data insights for healthcare providers and researchers to improve treatments.

Main solutions provided:

+ COVID 19 remote monitoring

+ COVID 19 hospital avoidance

+ electronic data capture

+ digital therapeutics

+ patient support programs

patientMpower integrated the MIR Spirobank Smart - App based spiromter.

At ATS 2018, patientMpower presented two publications of observational studies related to Idiopathic pulmonary fibrosis (IPF), a type of chronic scarring lung disease characterized by a progressive and irreversible decline in lung function.

remote monitoring of COVID-19 enables clinicians to preserve hospital resources for patients that need them most - whilst ensuring rapid triage at the first signs of deterioration.

patientMpower for COVID-19 enables early hospital discharge or avoids in-patient admission for patients who are suitable for remote monitoring whilst in self-isolation

Distinctive Features:

+ early warning system for patients and clinicians: patient data is available in real time for clinical review in the secure data portal. In-app alerts and data portal red flags provide warnings if oxygen saturation falls below set thresholds, with SMS alerts for on-call monitoring staff

+ who are they working with: patientMpower is service provider to Ireland’s Health Service Executive (HSE) for the national remote monitoring programme for COVID-19. Is also working with leading centres in the US.